r/biotech•2 mo. agoNotGenentechAZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER saysBiotech News 📰fiercepharma.com/pharma/azs-baxfendy-not-wort...fiercepharma.comPosted Aug 13, 2026, 4:44 PM UTC00ShareSave